Cargando…

Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy

Detalles Bibliográficos
Autores principales:	Baird, Jason, Friedman, David, Cottam, Benjamin, Crittenden, Marka, Gough, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649345/ http://dx.doi.org/10.1186/2051-1426-3-S2-P349

Ejemplares similares

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

Programmed cell death-1 blockade in combination with stereotactic radiation in an orthotopic mouse model of hepatocellular carcinoma
por: Friedman, David, et al.
Publicado: (2015)

Improved efficacy of radiation in combination with TGFβ inhibition in a colorectal cancer mouse model
por: Young, Kristina H, et al.
Publicado: (2013)

Immune consequences of CT-guided radiation therapy of mouse mammary tumors
por: Gough, Michael J, et al.
Publicado: (2013)

STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2017)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
por: Friedman, David J, et al.
Publicado: (2014)

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
por: Crittenden, Marka R., et al.
Publicado: (2012)

Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
por: Young, Kristina H., et al.
Publicado: (2016)

Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
por: Kovacsovics-Bankowski, Magdalena, et al.
Publicado: (2013)

ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control
por: Blair, Tiffany, et al.
Publicado: (2022)

The paradox of radiation and T cells in tumors
por: Gough, Michael J., et al.
Publicado: (2022)

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
por: Crittenden, Marka R., et al.
Publicado: (2016)

The TAM family as a therapeutic target in combination with radiation therapy
por: Tormoen, Garth W., et al.
Publicado: (2017)

The Impact of the Myeloid Response to Radiation Therapy
por: Gough, Michael J., et al.
Publicado: (2013)

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
por: Crittenden, Marka R., et al.
Publicado: (2018)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma
por: Gunderson, Andrew J., et al.
Publicado: (2019)

The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
por: Crittenden, Marka R., et al.
Publicado: (2013)

Intravenous oxygen administration in a rat model of hypoxia
por: Damiani, E, et al.
Publicado: (2015)

Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge
por: Yuan, Min, et al.
Publicado: (2015)

Pharmacokinetics of single intravenous bolus administration of propofol in preterm and term neonates
por: Allegaert, K, et al.
Publicado: (2007)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Effects of the intravenous administration of purine nucleosides guanosine or inosine against hemorrhagic shock in pigs
por: Schmidt, A, et al.
Publicado: (2012)

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Improving intravenous drugs administration in ICU and reducing drug incompatibilities: a nurselead interdisciplinary program
por: Lagabrielle, M, et al.
Publicado: (2015)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
por: Crittenden, Marka, et al.
Publicado: (2015)

Cerebral autoregulation testing in a porcine model of intravenously administrated E. coli induced fulminant sepsis
por: Molnar, L, et al.
Publicado: (2015)

Effects of intraoperative magnesium sulfate administration on postoperative tramadol requirement in liver transplant patients
por: Gucyetmez, B, et al.
Publicado: (2015)

Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines
por: Boerrigter, Guido, et al.
Publicado: (2011)

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
por: Crocenzi, Todd, et al.
Publicado: (2016)

Activation of the STING pathway enhances immunity and improves survival in a murine myeloid leukemia model
por: Curran, Emily, et al.
Publicado: (2014)

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
por: Foote, Jeremy, et al.
Publicado: (2015)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

P114 STING. Steroid Injections DurinG Covid-19. A cross speciality call
por: Hardman, Lotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lnqucm1illo39bmtc4e719eq3c